Tarsus Pharmaceuticals Market Sentiment

SPY770.73+0.22%QQQ722.85+0.73%BTC/USD83,109.89+0.21%DIA524.31−0.01%GLD377.24−0.11%TLT79.93−0.25%

Premium

Tarsus Pharmaceuticals Inc

TARSNASDAQ

Trade with Public

$71.03

1.532.2%

Last update: Oct 20, 4:00 PM

$71.03

1.532.2%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Tarsus Pharmaceuticals Market Sentiment

Market sentiment signals for Tarsus Pharmaceuticals (TARS): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 13.4% short float

Options Flow▼ 1.03 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

11 analysts

Options Flow (P/C)

1.03

More puts — Bearish

171 calls · 176 puts

Avg Consensus PT

$89

+25.4%

Highest Price Target

$116

+63.3%

Goldman Sachs

Lowest Price Target

$51

-28.2%

Goldman Sachs

Short Interest

13.4%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 24, 2026	Goldman Sachs	Andrea Newkirk—	+63.3%	$116	Reinstates	Buy
Sep 16, 2026	Barclays	Glen Santangelo—	+54.9%	$110	Reinstates	Overweight
Sep 8, 2026	Jefferies	Anthony Petrone—	+47.8%	$88 → $105	Maintained	Buy
Aug 12, 2026	Oppenheimer	Francois Brisebois—	+40.8%	$97 → $100	Maintained	Outperform
Jul 31, 2026	Mizuho	Graig Suvannavejh—	+38.0%	$100 → $98	Maintained	Outperform
Jul 21, 2026	Guggenheim	Brad Canino—	+25.3%	$90 → $89	Maintained	Buy
Jul 9, 2026	HC Wainwright & Co.	Matthew Caufield—	+23.9%	$88 → $88	Maintained	Buy
May 4, 2026	HC Wainwright & Co.	Matthew Caufield—	+23.9%	$88 → $88	Maintained	Buy
Feb 25, 2026	Oppenheimer	Francois Brisebois—	+47.8%	$95 → $105	Maintained	Outperform
Feb 25, 2026	Guggenheim	Eddie Hickman—	+26.7%	$87 → $90	Maintained	Buy
Dec 9, 2025	Barclays	Glen Santangelo—	+40.8%	$100	Initiate	Overweight
Nov 20, 2025	Mizuho	Graig Suvannavejh—	+40.8%	$100	Initiate	Outperform
Nov 5, 2025	Guggenheim	Eddie Hickman—	+22.5%	$84 → $87	Maintained	Buy
Oct 20, 2025	HC Wainwright & Co.	Matthew Caufield—	+23.9%	$72 → $88	Maintained	Buy
May 27, 2025	HC Wainwright & Co.	Matthew Caufield—	+1.4%	$72	Assumes	Buy
May 5, 2025	Goldman Sachs	Andrea Tan—	-28.2%	$46 → $51	Maintained	Neutral
May 2, 2025	Guggenheim	Eddie Hickman—	+18.3%	$78 → $84	Maintained	Buy
Mar 6, 2025	Jefferies	Anthony Petrone—	-18.3%	$54 → $58	Maintained	Buy
Feb 26, 2025	Guggenheim	Eddie Hickman—	+9.8%	$75 → $78	Maintained	Buy
Feb 26, 2025	HC Wainwright & Co.	Oren Livnat—	+2.8%	$73 → $73	Maintained	Buy
Feb 26, 2025	Barclays	Balaji Prasad—	-15.5%	$62 → $60	Maintained	Overweight
Feb 24, 2025	Guggenheim	Eddie Hickman—	—	—	Maintained	Buy
Feb 10, 2025	Guggenheim	Eddie Hickman—	—	—	Maintained	Buy
Jan 27, 2025	Barclays	Balaji Prasad—	-12.7%	$60 → $62	Maintained	Overweight
Jan 22, 2025	Oppenheimer	Francois Brisebois—	+1.4%	$65 → $72	Maintained	Outperform